Of note, due to the importance of its function, targeting EZH2 has been applied in EZH2 activation mutant lymphoma and diffuse intrinsic pontine glioma (McCabe et al., 2012; Mohammad et al., 2017). This evidence concerns the gene EZH2 and lymphoma.